Scribe Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 07, 2020
- Vertical
- Molecular Engineering
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Founders
- Benjamin Oakes, Brett Staahl, David Savage, Jennifer Doudna
- Company Description
- Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
- Market
- Genetic Medicine
- Location
- Alameda, California, USA
- Coinvestors
- Biogen Idec